Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | POLB | P06746 | 4/20 | 0.55 |
| ▸ | CASP6 | P55212 | 1/20 | 0.55 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14469601 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 | |
| SCHEMBL381246 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 | |
| SCHEMBL14577505 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 | |
| SCHEMBL24062391 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 | |
| SCHEMBL20346210 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 | |
| SCHEMBL23287488 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 | |
| SCHEMBL1462188 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 | |
| SCHEMBL713506 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 | |
| SCHEMBL59471 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 | |
| SCHEMBL5641704 | 0.84 | POLB (0.70) | ALDH1A1POLBCASP6CTDSP1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 657 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250034290-A1 | Functional Cyclic Olefin Polymer, Process for Obtaining the Same and Compositions Containing the Same | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2025-01-30 | — | — | US | claimed |
| CN-115038703-B | Preparation method of tofacitinib and intermediate product thereof | 阿尔第实业有限公司 | 2024-08-06 | — | — | CN | claimed |
| EP-3450439-B1 | METHOD FOR PRODUCING MONOMER FOR SINGLE-STRANDED NUCLEIC ACID MOLECULE | SUMITOMO CHEMICAL CO (JP) | 2021-01-20 | — | — | EP | claimed |
| US-10308672-B2 | Method for producing monomer for single-stranded nucleic acid molecule | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-06-04 | — | — | US | claimed |
| US-20190100540-A1 | METHOD FOR PRODUCING MONOMER FOR SINGLE-STRANDED NUCLEIC ACID MOLECULE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-04-04 | — | — | US | claimed |
| EP-2519100-B1 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF TAPENTADOL AND RELATED COMPOUNDS | MAPI PHARMA LTD (IL) | 2017-03-15 | — | — | EP | claimed |
| US-7288661-B2 | Process for the synthesis of (2S,3aS,7aS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid compounds and application in the synthesis of perindopril | LES LABORATOIRES SERVIER (FR) | 2007-10-30 | — | — | US | claimed |
| US-20070123581-A1 | Process for the synthesis of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid compounds and application in the synthesis of perindopril | LES LABORATOIRES SERVIER (FR) | 2007-05-31 | — | — | US | claimed |
| US-20070093663-A1 | Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof. | LES LABORATOIRES SERVIER (FR) | 2007-04-26 | — | — | US | claimed |
| US-6602649-B2 | Photolithography; using ultraviolet radiation | HYNIX SEMICONDUCTOR INC (KR) | 2003-08-05 | — | — | US | claimed |
| US-20020015912-A1 | Photoresist monomers, polymers thereof and photoresist compositions containing the same | HYNIX SEMICONDUCTOR INC. (KR) | 2002-02-07 | — | — | US | claimed |
| US-5670647-A | Method for recovering optically pure amino acid derivatives | SHIMADZU CORPORATION (JP) | 1997-09-23 | — | — | US | claimed |
| JP-59112945-A | — | — | None | — | — | JP | disclosed |
| JP-59122465-A | — | — | None | — | — | JP | disclosed |
| JP-55051045-A | — | — | None | — | — | JP | disclosed |
| US-20260144900-A1 | IN VIVO CROSSLINKABLE HYDROGELS WITH GOLD NANOPARTICLES FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| JP-S59112945-A | PREPARATION OF O-SUBSTITUTED-HYDROXYLAMINE | KOEI CHEM CO LTD | 1984-06-29 | — | — | JP | disclosed |
| US-4399210-A | O-NAPHTHOQUINONEDIAZIDE AND A DISCOLORING AGENT | FUJI PHOTO FILM COMPANY LTD. (JP) | 1983-08-16 | — | — | US | disclosed |
| JP-S5551045-A | PREPARATION OF ENDORPHIN | TAKEDA CHEM IND LTD | 1980-04-14 | — | — | JP | disclosed |
| US-4052373-A | O-AMINOESTER | FUJI PHOTO FILM CO., LTD. (JA) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308672-B2 | Method for producing monomer for single-stranded nucleic acid molecule | DNA2, POLM, POLRMT | ALDH1A1 1071/4885POLB 10/4885CASP6 495/4885 |
| US-20070093663-A1 | Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof. | QDPR, REN, ACE | ALDH1A1 82/4885POLB 2909/4885CASP6 1934/4885 |
| US-20190100540-A1 | METHOD FOR PRODUCING MONOMER FOR SINGLE-STRANDED NUCLEIC ACID MOLECULE | DNA2, POLM, POLRMT | ALDH1A1 1071/4885POLB 10/4885CASP6 495/4885 |
| US-20260144900-A1 | IN VIVO CROSSLINKABLE HYDROGELS WITH GOLD NANOPARTICLES FOR MEDICAL APPLICATIONS | KLK3, BPHL, BRDT | ALDH1A1 146/4885POLB 4155/4885CASP6 1123/4885 |
| US-20070123581-A1 | Process for the synthesis of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid compounds and application in the synthesis of perindopril | CYP2S1, TPH1, AGTR1 | ALDH1A1 55/4885POLB 3241/4885CASP6 2455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.